Search research articles
Contact Us
Filters
Showing results (11-20 of 89) with videos related to
Page
of 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 8, 1998
CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy
M Jensen, G Tan, S Forman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
A method for patient-specific absorbed dose estimation for internal beta emitters
L E Williams, A Liu, A A Raubitschek, et al.
Nuclear Medicine and Biology
|
June 25, 1998
Monte Carlo-assisted voxel source kernel method (MAVSK) for internal beta dosimetry
A Liu, L E Williams, J Y Wong, et al.
Oncology Reports
|
May 21, 2011
Breast-tumor xenograft targeting and therapy studies using radiolabeled chimeric anti-cea monoclonal-antibody t84.66
J Esteban, A Raubitschek, B Felder, et al.
Gynecologic Oncology
|
October 1, 1994
Continuous infusion chemotherapy as a radiation-enhancing agent for yttrium-90-radiolabeled monoclonal antibody therapy of a human tumor xenograft
S W Remmenga, D Colcher, O Gansow, et al.
Bioconjugate Chemistry
|
April 21, 2001
An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA
M R Lewis, J Y Kao, A L Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1983
Characterization of human hybridomas secreting antibody to tetanus toxoid
J W Larrick, K E Truitt, A A Raubitschek, et al.
Journal of Biological Response Modifiers
|
February 1, 1986
Purified interleukin-2 induces proliferation of fresh human lymphocytes in the absence of exogenous stimuli
J Lifson, A Raubitschek, C Benike, et al.
Cytotherapy
|
May 15, 2003
Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy
M C Jensen, L J N Cooper, A M Wu, et al.
Bioconjugate Chemistry
|
September 19, 2002
Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody
Lin Li, Tove Olafsen, Anne-Line Anderson, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 89) with videos related to
Sort By:
Page
of 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 8, 1998
CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy
M Jensen, G Tan, S Forman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
A method for patient-specific absorbed dose estimation for internal beta emitters
L E Williams, A Liu, A A Raubitschek, et al.
Nuclear Medicine and Biology
|
June 25, 1998
Monte Carlo-assisted voxel source kernel method (MAVSK) for internal beta dosimetry
A Liu, L E Williams, J Y Wong, et al.
Oncology Reports
|
May 21, 2011
Breast-tumor xenograft targeting and therapy studies using radiolabeled chimeric anti-cea monoclonal-antibody t84.66
J Esteban, A Raubitschek, B Felder, et al.
Gynecologic Oncology
|
October 1, 1994
Continuous infusion chemotherapy as a radiation-enhancing agent for yttrium-90-radiolabeled monoclonal antibody therapy of a human tumor xenograft
S W Remmenga, D Colcher, O Gansow, et al.
Bioconjugate Chemistry
|
April 21, 2001
An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA
M R Lewis, J Y Kao, A L Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1983
Characterization of human hybridomas secreting antibody to tetanus toxoid
J W Larrick, K E Truitt, A A Raubitschek, et al.
Journal of Biological Response Modifiers
|
February 1, 1986
Purified interleukin-2 induces proliferation of fresh human lymphocytes in the absence of exogenous stimuli
J Lifson, A Raubitschek, C Benike, et al.
Cytotherapy
|
May 15, 2003
Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy
M C Jensen, L J N Cooper, A M Wu, et al.
Bioconjugate Chemistry
|
September 19, 2002
Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody
Lin Li, Tove Olafsen, Anne-Line Anderson, et al.
Page
of 9